<DOC>
	<DOCNO>NCT02645565</DOCNO>
	<brief_summary>This study conduct find whether low dose high dose cyclophosphamide therapy effective treatment proliferative lupus nephritis.It also compare side effect risk infection low dose high dose cyclophosphamide group . Half participant receive low dose cyclophosphamide 3 month half receive high dose cyclophosphamide therapy monthly 6 month follow azathioprine 2 mg/kg .</brief_summary>
	<brief_title>Comparison Low Dose Versus High Dose Cyclophosphamide Induction Therapy Treatment Lupus Nephritis</brief_title>
	<detailed_description>The study conduct Department Clinical Immunology , Jawaharlal Institute Postgraduate Medical Education &amp; Research ( JIPMER ) . Once patient diagnosed systemic lupus erythematosus ( SLE ) lupus nephritis satisfy inclusion criterion , informed nature severity disease expect treatment option duration treatment . After provide write informed consent , eligible patient stratify two group . Block randomization do generate random allocation sequence.They receive either low dose high dose Cyclophosphamide per protocol mention : Group I : Low dose arm : Intravenous cyclophosphamide fix pulse 500 mg 2 weekly total 6 dos follow azathioprine 2 mg/kg . Group II : High Dose arm : Intravenous cyclophosphamide therapy 750 mg/m2 give every 4 weekly total 6 dos follow azathioprine 2 mg/kg . Intravenous methylprednisolone pulse 1 gm give 3 day treatment arm follow prednisolone 1 mg/kg 4 week taper 5 mg every 2 week . Additional drug per indication like hydroxychloroquine , antihypertensives cotrimoxazole prophylaxis shall also give unless contraindicate . There monitor treatment efficacy side effect treatment arm</detailed_description>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>1 . A diagnosis SLE accord American College Rheumatology ( ACR ) criteria 2 . Age &gt; 16 year 3 . Proteinuria â‰¥500 mg 24 hours/ urine routine microscopy show active cellular casts/sediments . 4 . Biopsyproven proliferative lupus glomerulonephritis class III , IV accord International Society Nephrology/Renal Pathology Society ( ISN/RPS ) criterion . 1 . Patients ever treat previously intravenous oral cyclophosphamide receive steroid &gt; 15mg/day last 3 month . 2 . Patients renal thrombotic microangiopathy , preexist chronic renal failure , pregnancy , previous malignancy ( except skin cervical intraepithelial neoplasia ) , diabetes mellitus coronary heart disease . 3 . Patients previously document severe toxicity immunosuppressive drug . 4 . Patients acute/chronic infection . 5 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>